What side effects does Emflaza (deflazacort) cause?
Emflaza (deflazacort) is a corticosteroid. Side effects typically reflect known steroid effects—especially with longer use or higher doses.
Commonly reported steroid-related side effects include weight gain, increased appetite, mood changes (such as irritability), trouble sleeping, and gastrointestinal upset.
Because Emflaza is a systemic steroid, it can also raise the risk of infections, cause changes in blood sugar and blood pressure, and lead to muscle weakness and fluid retention. Long-term steroid exposure can affect bones (osteoporosis), growth in children, and skin (thinning or easy bruising).
What are the serious Emflaza side effects that need urgent care?
Patients and caregivers are generally advised to seek urgent medical attention for signs that may indicate complications from steroids, such as:
- Signs of infection (fever, chills, worsening cough, painful urination)
- Severe allergic-type reactions (swelling of the face or throat, trouble breathing)
- Significant mood or behavioral changes (especially if severe or accompanied by confusion)
- High blood sugar symptoms (increased thirst/urination, blurry vision)
- Severe swelling, shortness of breath, or chest pain
If any of these occur, contacting a clinician promptly is important.
How can Emflaza affect children differently than adults?
Emflaza is used for certain muscular dystrophy conditions, including in children. In pediatric use, steroid effects can include:
- Slowing growth or changes in growth trajectory
- Increased risk of weight gain
- Bone effects over time (including reduced bone density)
- Behavioral and sleep changes
Monitoring growth, weight, blood pressure, and bone health is especially relevant for children on chronic steroid therapy.
What should patients watch for over time (long-term risks)?
With ongoing corticosteroid treatment, the risks that often come up include:
- Bone weakening (osteoporosis) and fracture risk
- Cataracts or increased eye pressure (glaucoma)
- Steroid-induced muscle weakness
- Metabolic effects such as elevated blood sugar and changes in cholesterol
- Higher susceptibility to infections
Clinicians often balance benefits against these risks and may add monitoring and preventive steps (for example, bone-protective strategies and infection precautions).
Can Emflaza cause infections, and how can patients reduce that risk?
Because corticosteroids suppress immune responses, they can increase infection risk. Practical steps typically include staying up to date on recommended vaccines (discuss timing with the prescriber), reporting fevers early, and avoiding close contact with people who have contagious illnesses.
Any infection that develops should be evaluated promptly because steroid therapy can blunt typical warning signs.
What happens if Emflaza is stopped suddenly?
With corticosteroids, stopping abruptly can be unsafe after sustained use. Steroids often require a taper plan directed by the prescribing clinician to reduce the risk of adrenal insufficiency. Any change in dosing should be coordinated with the prescriber.
Where can I check Emflaza safety info and updates?
For patent and product-related updates, DrugPatentWatch.com may be useful background, including information tied to the drug’s commercial status: https://www.drugpatentwatch.com/ (no specific Emflaza safety claims found from the provided context).